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HaplotypesAbstract Background: Azoospermia constitutes 20% of male infertility situations and affects 1%
of the total male population (Jarvi et al., 2010). This condition is classiﬁed into three major types;
pre-testicular, testicular and post-testicular Azoospermia (Sermondade et al., 2012). Genetic defects
causing Azoospermia are due to chromosomal or non-chromosomal alterations on the
Y-Chromosome (Lee et al., 2011). Initial diagnosis of Azoospermia is established when no sperma-
tozoa are detected on microscopic examination of semen (World Health Organisation, 1999).
Objective: To evaluate the correlation of Y-STR Proﬁling results and the prevalence of
Azoospermia, to help for early prognosis of Azoospermia before puberty.
Methods: Buccal swab samples were taken from two groups of individuals (50 fertile and 50
Azoospermic patients), then DNA was isolated using QIAamp DNA Micro kit. DNA quantiﬁca-
tion was done using a Real-time PCR utilizing Quantiﬁler Kit. PCR was done using PowerPlex Y
PCR Ampliﬁcation Kit, then ampliﬁed products were typed using a 3130 Genetic Analyzer.
Results: Five haplotypes in four different Y-STR loci were found to possess signiﬁcantly higher
occurrence percentages in Azoospermic than in fertile Saudi individuals, which can serve as a group
of pre-diagnostic markers for early prognosis of Azoospermia in Saudi population.
Conclusion: There was a signiﬁcant correlation of Y-STR Proﬁling results and the prevalence of
Azoospermia condition, which supports the idea of using Y-STR Proﬁling in early prognosis of
Azoospermia.
 2015 The Auhor. Production and hosting by Elsevier B.V. on behalf of Ain Shams University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Infertility is deﬁned as a failure to conceive in a couple trying
to reproduce for a period of 2 years without conception.Approximately 15% of couples are infertile, and among these
couples, male factor infertility accounts for approximately
50% of causes. Male infertility is a multifactorial syndrome
encompassing a wide variety of disorders. Male infertility is
most likely the result of deletions and/or mutations of one or
more of the myriad of genes required for spermatogenesis
[1]. Azoospermia is the most severe form of male infertility,
it is the medical condition of a man not having any measurable
level of sperm in his semen. In humans, Azoospermia affects
Figure 1 Relative positions of Y-STRs on human Y-
Chromosome [20].
48 A.M. Refaatabout 1% of the male population and may be seen in up to
20% of male infertility situations [2].
Azoospermia can be classiﬁed into three major types; pre-
testicular Azoospermia which is characterized by inadequate
stimulation of otherwise normal testicles and genital tract.Table 1 Fisher’s exact test for comparing the percent of Y-STR hap
STR locus (DYS19).
Y-STR locus Haplotype Group No. of observations H
DYS19 10 Azoospermic – –
Fertile – –
11 Azoospermic – –
Fertile – –
12 Azoospermic 1 0
Fertile 1 0
13 Azoospermic 5 0
Fertile 2 0
14 Azoospermic 37 0
Fertile 38 0
15 Azoospermic 2 0
Fertile 8 0
16 Azoospermic 4 0
Fertile 1 0
17 Azoospermic 1 0
Fertile – –
18 Azoospermic – –
Fertile – –
19 Azoospermic – –
FertileTypically, follicle-stimulating hormone (FSH) levels are low
(hypogonadotropic) commensurate with inadequate stimula-
tion of the testes to produce sperm. This condition is seen in
about 2% of Azoospermia patients [3]. Testicular
Azoospermia in which the testes are abnormal, atrophic, or
absent, and sperm production is severely disturbed to absent.
FSH levels tend to be elevated (hypergonadotropic) as the
feedback loop is interrupted (lack of feedback inhibition on
FSH). This condition is seen in 49–93% of men with
Azoospermia [2]. Post-testicular Azoospermia in which sperms
are produced but not ejaculated. This condition affects 7–51%
of Azoospermic men. Idiopathic Azoospermia is the condition
in which there is no known cause of Azoospermia. It may be a
result of multiple risk factors, such as age and weight [4].
Y Chromosome is one of the smallest human chromosomes
and consists of a short (Yp) and a long (Yq) arm. The Y
Chromosome is male-speciﬁc, 60 megabases (Mb) in size, con-
sisting of 60 million nucleotides, but has the least number of
genes compared to any other chromosome. Of the 27 Y
Chromosome genes identiﬁed, nine are located on the Yp
and the remaining 18 on the Yq [5]. In 1976, Tiepolo and
Zuffardi were the ﬁrst to hypothesize a correlation between
Y Chromosome deletions and male infertility [6].
The initial diagnosis of Azoospermia is established when no
spermatozoa can be detected on high-powered microscopic
examination of a pellet after centrifugation of the seminal ﬂuid
on at least two separate occasions. The World Health
Organization (WHO) recommends that seminal ﬂuid be cen-
trifuged for 15 min at 3000·g or greater [7].
Genetic defects causing Azoospermia were categorized into
two large categories: chromosomal and nonchromosomal.
Chromosomal defects were further categorized into (1) struc-
tural abnormalities, such as Y Chromosome micro/macrodele-
tions, chromosomal inversions, and translocations; and (2)
numerical abnormalities, also known as aneuploidy.
Nonchromosomal defects included sperm mitochondrial gen-
ome defects and epigenetic alterations of genome [8].lotypes detected in Azoospermic and fertile individuals in the Y-
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Table 2 Fisher’s exact test for comparing the percent of Y-STR haplotypes detected in Azoospermic and fertile individuals in the Y-
STR locus (DYS385a).
Y-STR locus Haplotype Group No. of observations Haplotype frequency Estimate for diﬀerence Z P-value
DYS385a 7 Azoospermic – – – – –
Fertile – –
8 Azoospermic – – – – –
Fertile – –
9 Azoospermic – – – – –
Fertile – – – – –
10 Azoospermic – – – – –
Fertile – –
11 Azoospermic 2 0.04 0.02 0.59 0.279
Fertile 1 0.02
12 Azoospermic 1 0.02 0.04 1.03 0.848
Fertile 3 0.06
13 Azoospermic 33 0.66 0.02 0.21 0.417
Fertile 32 0.64
14 Azoospermic 3 0.06 0.02 0.46 0.323
Fertile 2 0.04
15 Azoospermic 3 0.06 0 0 0.500
Fertile 3 0.06
16 Azoospermic 4 0.08 0.02 0.35 0.637
Fertile 5 0.10
17 Azoospermic 2 0.04 0.02 0.59 0.279
Fertile 1 0.02
18 Azoospermic 2 0.04 0.02 0.46 0.677
Fertile 3 0.06
19 Azoospermic – – – – –
Fertile – –
20 Azoospermic – – – – –
Fertile – –
21 Azoospermic – – – – –
Fertile – –
22 Azoospermic – – – – –
Fertile – –
23 Azoospermic – – – – –
Fertile – –
24 Azoospermic – – – – –
Fertile – –
25 Azoospermic – – – – –
Fertile – –
Early prognosis of Azoospermia in relation to Y-STR Proﬁling 49Chromosomal abnormalities can be identiﬁed by karyotype
of peripheral leukocytes in approximately 7% of infertile
men. The prevalence of such abnormalities relates inversely
to the sperm concentration; the prevalence is 10–15% in
Azoospermic men. Sex chromosomal aneuploidy (Klinefelter
syndrome) accounts for approximately two-thirds of chromo-
somal abnormalities observed in infertile men [9].
Microdeletions of the Y-Chromosome may be found in 10–
15% of men with Azoospermia. Such microdeletions are too
small to be detected by karyotyping but can be identiﬁed using
PCR techniques to analyze sequence-tagged sites that have
been mapped along the entire length of the Y-Chromosome
[10]. Genetic counseling may be offered whenever a genetic
abnormality is suspected, in either the male or the female part-
ner, and should be provided whenever a genetic abnormality is
detected [11].
Y-STRs are Short Tandem Repeats found on the male-
speciﬁc Y Chromosome (Fig. 1). They are often used in foren-
sics, paternity, and genealogical DNA testing as they have the
ability to link male individuals from the same paternal lineage.
Y-STR Proﬁling involves simple and reliable PCR techniquesand is tolerant of very degraded samples, besides it can be
employed as an investigative tool presenting solutions for solv-
ing several mysterious forensic cases [12]. The forensic utility
of Y-STRs results from their high levels of polymorphism
in human populations, their small size in base pairs
(100–400 bp), and the ability to type multiple Y-STRs in a
single PCR reaction [13].
The aim of the present study was to evaluate the correlation
of Y-STR Proﬁling results and the prevalence of Azoospermia
condition.
2. Subjects and methods
2.1. Samples
One hundred buccal swab samples from one hundred individ-
uals all subjected to semen analysis were included in this study
and are categorized into two groups:
Group I (control group): consists of 50 buccal swab sam-
ples taken from men aged from 25 to 40 years from the
Saudi population after their informed consents, and it was
Table 3 Fisher’s exact test for comparing the percent of Y-STR haplotypes detected in Azoospermic and fertile individuals in the
Y-STR locus (DYS385b).
Y-STR locus Haplotype Group No. of observations Haplotype frequency Estimate for diﬀerence Z P-value
DYS385b 7 Azoospermic – – – – –
Fertile – –
8 Azoospermic – – – – –
Fertile – –
9 Azoospermic – – – – –
Fertile – – – – –
10 Azoospermic – – – – –
Fertile – –
11 Azoospermic – – – – –
Fertile – –
12 Azoospermic – – 0.02 1.01 0.844
Fertile 1 0.02
13 Azoospermic – – 0.02 1.01 0.844
Fertile 1 0.02
14 Azoospermic 2 0.04 0.02 0.59 0.279
Fertile 1 0.02
15 Azoospermic – – 0.02 1.01 0.844
Fertile 1 0.02
16 Azoospermic 3 0.06 0 0 0.500
Fertile 3 0.06
17 Azoospermic 10 0.20 0.06 0.71 0.763
Fertile 13 0.26
18 Azoospermic 14 0.28 0.02 0.22 0.587
Fertile 15 0.30
19 Azoospermic 18 0.36 0.14 1.56 0.059
Fertile 11 0.22
20 Azoospermic 1 0.02 0.04 1.03 0.848
Fertile 3 0.06
21 Azoospermic 2 0.04 0.02 0.59 0.279
Fertile 1 0.02
22 Azoospermic – – – – –
Fertile – –
23 Azoospermic – – – – –
Fertile – –
24 Azoospermic – – – – –
Fertile – –
25 Azoospermic – – – – –
Fertile – –
50 A.M. Refaatproved from the results indicated in the report of their semen
analysis that they are all having normal sperm count and char-
acteristics and they are all fertile persons.
Group II (patients group): consists of 50 buccal swab sam-
ples taken from men aged from 25 to 40 years from the Saudi
population after their informed consents, and it was proved
from the results indicated in the report of their semen analysis
that they all have Azoospermia (sperm count = 0).
A photocopy for the clinical report of semen analysis done
for each individual (from both groups) was obtained from a
private clinical lab in Riyadh prior to taking buccal swab sam-
ples in the duration from September to March 2014. All buccal
swab samples taken were collected and stored at 20 C till
DNA extraction was performed.
2.2. DNA extraction
Total genomic DNA was extracted from buccal swab samples
from both groups of individuals included in the study using a
QIAamp DNA Micro kit (Qiagen) with the ‘‘DNAPuriﬁcation from buccal swabs (Spin Protocol)’’ [14]. The
extracted DNA was stored at 4 C for less than 2 weeks until
further processing.
2.3. DNA quantitation
Two microliters of each extracted sample was quantiﬁed with a
Quantiﬁler Kit (Life Technologies) according to manufac-
turer’s protocol [15] using a Real-time PCR 7500 system
(Applied Biosystems).
2.4. DNA ampliﬁcation
The PowerPlex Y PCR Ampliﬁcation Kit was used to
amplify the following twelve Y-STR loci: DYS19, DYS385a,
DYS385b, DYS389I, DYS389II, DYS390, DYS391,
DYS392, DYS393, DYS437, DYS438 and DYS439 located
on the Y-Chromosome [16]. DNA was ampliﬁed according
to manufacturer’s recommendations using a GeneAmp
PCR System Veriti thermal cycler (Applied Biosystems). The
Table 4 Fisher’s exact test for comparing the percent of Y-STR haplotypes detected in Azoospermic and fertile individuals in the Y-
STR locus (DYS389I).
Y-STR locus Haplotype Group No. of observations Haplotype frequency Estimate for diﬀerence Z P-value
DYS389I 10 Azoospermic – – – – –
Fertile – –
11 Azoospermic – – – – –
Fertile – –
12 Azoospermic 1 0.02 0.04 1.03 0.848
Fertile 3 0.06
13 Azoospermic 43 0.86 0.08 1.05 0.148
Fertile 39 0.78
14 Azoospermic 6 0.12 0.04 0.58 0.718
Fertile 8 0.16
15 Azoospermic – – – – –
Fertile – –
Table 5 Fisher’s exact test for comparing the percent of Y-STR haplotypes detected in Azoospermic and fertile individuals in the Y-
STR locus (DYS389II).
Y-STR locus Haplotype Group No. of observations Haplotype frequency Estimate for diﬀerence Z P-value
DYS389II 24 Azoospermic – – – – –
Fertile – –
25 Azoospermic – – – – –
Fertile – –
26 Azoospermic – – – – –
Fertile – – – – –
27 Azoospermic – – – – –
Fertile – –
28 Azoospermic – – 0.02 1.01 0.844
Fertile 1 0.02
29 Azoospermic 6 0.12 0.24 2.93 0.998
Fertile 18 0.36
30 Azoospermic 35 0.70 0.32 3.39 0.000
Fertile 19 0.38
31 Azoospermic 6 0.12 0.04 0.58 0.718
Fertile 8 0.16
32 Azoospermic 3 0.06 0.02 0.39 0.653
Fertile 4 0.08
33 Azoospermic – – – – –
Fertile – –
34 Azoospermic – – – – –
Fertile – – – – –
Early prognosis of Azoospermia in relation to Y-STR Proﬁling 51amount of template DNA added to the reaction mixture was
dependent upon the Real-Time PCR results, with an optimal
concentration of 0.5 ng/ll and a volume of 19.45 ll DNA sam-
ple. A negative control was made with 19.45 ll of deionized
water and a positive control was made by vortexing the tube
of 2800 M control DNA, then diluting an aliquot to 0.5 ng
in 19.45 ll deionized water into a reaction tube, then adding
PCR ampliﬁcation mix for PowerPlex Y kit [17].
The ampliﬁcation reaction for PowerPlex Y multiplex sys-
tem was run in the following conditions: 95 C for 11 min as an
initial hold; 96 C for 1 min; (ramp 100% to 94 C for 30 s,
ramp 29% to 60 C for 30 s, ramp 23% to 70 C for 45 s)
for 10 cycles; (ramp 100% to 90 C for 30 s, ramp 29% to
58 C for 30 s, ramp 23% to 70 C for 45 s) for 22 cycles;
60 C for 30 min; and 4 C forever as a ﬁnal hold [17].Ampliﬁed samples were stored at 4 C for less than 2 weeks
until further processing.
2.5. STR genotyping
One microliter of PCR product from each sample was mixed
with 9.5 ll of Hi-Di formamide and 0.5 ll ILS 600 size stan-
dard. The mixture was denatured at 95 C for 3 min and
cooled to 4 C for 3 min. Electrophoresis was performed on
an ABI 3130 Genetic Analyzer using POP4 polymer.
Samples were injected for 5 s at 3 kV, and then run at 15 kV
for 2000 s at a constant temperature of 60 C. The raw data
were collected using 3130 Data Collection software, version
3.0 and analyzed using GeneMapper ID-X software, version
1.0. Genotypes were determined by comparing the size of the
Table 6 Fisher’s exact test for comparing the percent of Y-STR haplotypes detected in Azoospermic and fertile individuals in the Y-
STR locus (DYS390).
Y-STR locus Haplotype Group No. of observations Haplotype frequency Estimate for diﬀerence Z P-value
DYS390 18 Azoospermic – – – – –
Fertile – –
19 Azoospermic – – – – –
Fertile – –
20 Azoospermic – – – – –
Fertile – –
21 Azoospermic 1 0.02 0.06 1.39 0.918
Fertile 4 0.08
22 Azoospermic 4 0.08 0.02 0.35 0.637
Fertile 5 0.10
23 Azoospermic 42 0.84 0.18 2.12 0.017
Fertile 33 0.66
24 Azoospermic 3 0.06 0.06 1.05 0.854
Fertile 6 0.12
25 Azoospermic – – 0.04 1.44 0.926
Fertile 2 0.04
26 Azoospermic – – – – –
Fertile – –
27 Azoospermic – – – – –
Fertile – –
Table 7 Fisher’s exact test for comparing the percent of Y-STR haplotypes detected in Azoospermic and fertile individuals in the Y-
STR locus (DYS391).
Y-STR locus Haplotype Group No. of observations Haplotype frequency Estimate for diﬀerence Z P-value
DYS391 7 Azoospermic – – – – –
Fertile – –
8 Azoospermic – – – – –
Fertile – –
9 Azoospermic – – 0.02 1.01 0.844
Fertile 0.02
10 Azoospermic 18 0.36 0.1 1.02 0.847
Fertile 23 0.46
11 Azoospermic 24 0.48 0.02 0.20 0.421
Fertile 23 0.46
12 Azoospermic 8 0.16 0.1 1.62 0.053
Fertile 3 0.06
13 Azoospermic – – – – –
Fertile – –
52 A.M. Refaatunknown fragments to the allelic ladders provided by the man-
ufacturer [17]. All the work in this study has been carried out
in accordance with The Code of Ethics of the World Medical
Association (Declaration of Helsinki) for experiments in
human.
2.6. Statistical analysis
To compare the haplotype frequencies for each haplotype in
each Y-STR locus included in the PowerPlex Y PCR
ampliﬁcation kit, between the group of Azoospermic and
the group of fertile individuals, a Fisher’s exact test was
performed to assess the level of signiﬁcance (0.05) using the
following two hypothesis [21] and the results are shown in
Tables 1–12:Null hypothesis H0. The percent of occurrence of the haplo-
type in Azoospermic individuals (PAzoospermic) 6 the percent of
occurrence of the haplotype in fertile individuals (PFertile).
Alternative hypothesis H1. The percent of occurrence of the
haplotype in Azoospermic individuals (PAzoospermic) > the per-
cent of occurrence of the haplotype in fertile individuals
(PFertile).3. Results and discussion
From the statistical results represented in Tables 1–12, we
observe that ﬁve haplotypes in four Y-STR loci have been
detected with various occurrence percentages in Azoospermic
individuals, more greater than their occurrence percentages
Table 8 Fisher’s exact test for comparing the percent of Y-STR haplotypes detected in Azoospermic and fertile individuals in the Y-
STR locus (DYS392).
Y-STR locus Haplotype Group No. of observations Haplotype frequency Estimate for diﬀerence Z P-value
DYS392 7 Azoospermic – – – – –
Fertile – –
8 Azoospermic – – – – –
Fertile – –
9 Azoospermic – – – – –
Fertile – –
10 Azoospermic 4 0.08 0.06 0.96 0.832
Fertile 7 0.14
11 Azoospermic 40 0.80 0 0 0.500
Fertile 40 0.80
12 Azoospermic – – – – –
Fertile – –
13 Azoospermic 5 0.10 0.08 1.71 0.044
Fertile 1 0.02
14 Azoospermic – – 0.02 1.01 0.844
Fertile 1 0.02
15 Azoospermic 1 0.02 0 0 0.500
Fertile 1 0.02
16 Azoospermic – – – – –
Fertile – –
17 Azoospermic – – – – –
Fertile – –
18 Azoospermic – – – – –
Fertile – –
Table 9 Fisher’s exact test for comparing the percent of Y-STR haplotypes detected in Azoospermic and fertile individuals in the Y-
STR locus (DYS393).
Y-STR locus Haplotype Group No. of observations Haplotype frequency Estimate for diﬀerence Z P-value
DYS393 8 Azoospermic – – – – –
Fertile – –
9 Azoospermic 1 0.02 0.02 1.01 0.156
Fertile – –
10 Azoospermic 10 0.20 0.20 3.54 0.000
Fertile – –
11 Azoospermic 3 0.06 0.06 1.79 0.037
Fertile – –
12 Azoospermic 28 0.56 0.14 1.47 0.929
Fertile 35 0.70
13 Azoospermic 5 0.10 0.16 2.13 0.983
Fertile 13 0.26
14 Azoospermic – – 0.02 1.01 0.844
Fertile 1 0.02
15 Azoospermic 2 0.04 0.02 0.59 0.279
Fertile 1 0.02
16 Azoospermic 1 0.02 0.02 1.01 0.156
Fertile – –
Early prognosis of Azoospermia in relation to Y-STR Proﬁling 53in fertile individuals. The statistical results for those ﬁve hap-
lotypes are assembled in Table 13.
From the statistical results shown in Table 13, we found
that the calculated P-value was less than the statistical level
of signiﬁcance (1= 0.05) in the ﬁve haplotypes; 30, 23, 13,
10 and 11 present in the Y-STR loci; DYS389II, DYS390,
DYS392 and DYS393(2) respectively. This led to the accep-
tance of the alternative hypothesis (H1) of Fisher’s exact test,
which states that the percent of occurrence of each of these ﬁvehaplotypes in Azoospermic individuals is signiﬁcantly higher
than the percent of the occurrence of the same haplotype in
fertile individuals. Accordingly, those haplotypes can be
selected and grouped as pre-diagnostic markers which can pre-
dict for the incidence of Azoospermia condition among Saudi
individuals.
The prevalence of any of these ﬁve haplotypes in the
Y-STR proﬁle of a Saudi male individual, may increase the
probability of occurrence of Azoospermia condition in this
Table 10 Fisher’s exact test for comparing the percent of Y-STR haplotypes detected in Azoospermic and fertile individuals in the Y-
STR locus (DYS437).
Y-STR locus Haplotype Group No. of observations Haplotype frequency Estimate for diﬀerence Z P-value
DYS437 13 Azoospermic – – – – –
Fertile – –
14 Azoospermic 48 0.96 0.04 0.85 0.199
Fertile 46 0.92
15 Azoospermic 2 0.04 0.02 0.46 0.677
Fertile 3 0.06
16 Azoospermic – – 0.02 1.01 0.844
Fertile 1 0.02
17 Azoospermic – – – – –
Fertile – –
Table 11 Fisher’s exact test for comparing the percent of Y-STR haplotypes detected in Azoospermic and fertile individuals in the Y-
STR locus (DYS438).
Y-STR locus Haplotype Group No. of observations Haplotype frequency Estimate for diﬀerence Z P-value
DYS438 8 Azoospermic – – – – –
Fertile – –
9 Azoospermic 4 0.08 0.02 0.35 0.637
Fertile 5 0.10
10 Azoospermic 40 0.80 0.02 0.25 0.403
Fertile 39 0.78
11 Azoospermic 5 0.10 0.02 0.32 0.625
Fertile 6 0.12
12 Azoospermic 1 0.02 0.02 1.01 0.156
Fertile – –
13 Azoospermic – – – – –
Fertile – –
Table 12 Fisher’s exact test for comparing the percent of Y-STR haplotypes detected in Azoospermic and fertile individuals in the Y-
STR locus (DYS439).
Y-STR locus Haplotype Group No. of observations Haplotype frequency Estimate for diﬀerence Z P-value
DYS439 8 Azoospermic 1 0.02 0.02 1.01 0.156
Fertile – –
9 Azoospermic 3 0.06 0.04 1.03 0.152
Fertile 1 0.02
10 Azoospermic 1 0.02 0 0 0.500
Fertile 1 0.02
11 Azoospermic 30 0.60 0 0 0.500
Fertile 30 0.60
12 Azoospermic 12 0.24 0.1 1.11 0.866
Fertile 17 0.34
13 Azoospermic 3 0.06 0.04 1.03 0.152
Fertile 1 0.02
14 Azoospermic – – – – –
Fertile – –
15 Azoospermic – – – – –
Fertile – –
54 A.M. Refaatindividual in Saudi population. Since all STR loci obey the law
of independent assortment stated by Mendel [19] and are
therefore inherited independently, so the occurrence of more
than one haplotype of those ﬁve haplotypes in Table 13 in
the Y-STR proﬁle of a Saudi male individual, will give riseto the prediction of Azoospermia condition in this individual
with more increasing percentage.
When comparing our Y-STR haplotype frequency results
of the group of the ﬁve haplotypes chosen as pre-diagnostic
markers for Azoospermia in fertile individuals, with the
Table 13 Statistical results for pre-diagnostic Y-STR haplotype markers for Azoospermia.
Y-STR locus Haplotype Group No. of observations Haplotype frequency Estimate for diﬀerence Z P-value
DYS389II 30 Azoospermic 35 0.70 0.32 3.39 0.000
Fertile 19 0.38
DYS390 23 Azoospermic 42 0.84 0.18 2.12 0.017
Fertile 33 0.66
DYS392 13 Azoospermic 5 0.10 0.08 1.71 0.044
Fertile 1 0.02
DYS393 10 Azoospermic 10 0.20 0.20 3.54 0.000
Fertile – –
11 Azoospermic 3 0.06 0.06 1.79 0.037
Fertile – –
Table 14 Comparison of Y-STR haplotype frequencies in four different populations.
Y-STR locus Haplotype Turkish population Chinese population Libyan population Saudi population
DYS389II 30 0.40 0.22 0.17 0.38
DYS390 23 0.38 0.30 0.47 0.66
DYS392 13 0.08 0.20 0.03 0.02
DYS393 10 – – – –
11 0.02 – 0.02 –
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loci in three different populations (Table 14), we found that
there is a close proximity in the Y-STR haplotype frequency
values between the four populations [18,22,23].
When comparing the Y-STR haplotype frequency values in
the three haplotypes; 30, 23 and 13 in the three Y-STR loci;
DYS389II, DYS390, and DYS392 respectively, in the four
populations, we found a great convergence between the corre-
sponding haplotype frequency values in each Y-STR locus in
the four different populations.
In the Y-STR locus (DYS393); there was a complete
absence of the haplotype ‘‘10’’ in all populations, and regard-
ing the haplotype ‘‘11’’ in the same locus, it was absent in both
the Saudi and the Chinese populations, while it possesses a
very low frequency reaches (0.02) in both Turkish and
Libyan populations.
Moreover, all frequency values in the ﬁve Y-STR haplo-
types in all populations were less than the corresponding fre-
quency values of the Azoospermic Saudi individuals included
in the study except for the haplotype ‘‘13’’ in the Y-STR locus
(DYS392) in the chinese population which was found to have a
frequency value reached (0.20) in contrast to the correspond-
ing frequency values (0.08), (0.03), and (0.02) in the Turkish,
Libyan, and Saudi populations respectively. This supports
the idea that the ﬁve Y-STR haplotypes chosen in our study,
can be utilized as pre-diagnostic markers for Azoospermia pre-
diction in more populations after similar statistics done.
4. Conclusion
It was found that there are ﬁve haplotypes located within four
different Y-STR loci that can serve as a group of pre-
diagnostic markers for early prognosis of Azoospermia in
Saudi population.Consequently, we can conclude that performing Y-STR
Proﬁling including the four Y-STR loci; DYS389II,
DYS390, DYS392 and DYS393 for newborn Saudi males,
will be beneﬁcial in predicting Azoospermia condition, in case
that there is one or more of this group of ﬁve haplotypes in
those four Y-STR loci is detected in the Y-STR genotyping
results.
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